ArticleJournal of advanced pharmaceutical technology & research
Nanostructured lipid carrier system encapsulating bergamot essential oil within an ionic gel-virgin coconut oil matrix: A promising approach for skin health care.
Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin aging is a biological process, characterized by wrinkle formation, loss of elasticity, and decreased hydration. It is influenced by intrinsic and extrinsic factors, including ultraviolet (UV) exposure, pollution, and oxidative stress. This study developed a topical formulation combining bergamot essential oil (EOBs) and virgin coconut oil within an ionic gel system, encapsulated in nanostructured lipid carriers (NLCs), aiming to provide anti-aging, moisturizing, and UV-protective benefits. The GEOBs-VNLCs ionic gel formulation was prepared using a gelation method that combined sonication with dropwise stirring, followed by encapsulation within an NLC matrix via heating and homogenization, involving the formation of lipid and aqueous phases. The GEOBs-VNLCs formulation exhibited an average particle size of 140 ± 1.79 nm, low polydispersity (0.24 ± 0.02), negative zeta potential (-31.93 ± 1.17 mV), skin-compatible pH (5.13 ± 0.12), and high encapsulation efficiency (69.20 ± 0.57%), indicating good physicochemical stability for topical application. The formulation demonstrated moderate antioxidant activity (Half-maximal inhibitory concentration 7.39 μg/mL; 0.288 mg AAE/g dw), negligible improvement in skin hydration (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.